Department of Dermatology

Mastocytosis in the age of precision medicine: Position paper of the German Society of Allergy (AeDA) on the management of indolent systemic mastocytosis (2025) Siebenhaar F, Brehler R, Christen D, Hartmann K, Altrichter S, Joest M, aufm Kampe K, et al. Journal article Secondary resistance to sonidegib is rare in locally advanced basal cell carcinoma (2025) Muñoz Couselo E, Berking C, Baurain JF, Martelli S, Arntz R, Savoia P Journal article Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg. (2025) Forschner A, Kähler KC, Gschnell M, Langan EA, Weishaupt C, Meiss F, Thoms KM, et al. Journal article Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status (2025) Placke JM, Rajcsanyi LS, Herbst R, Terheyden P, Utikal J, Pföhler C, Kreuter A, et al. Journal article Avelumab mediates antibody-dependent cellular cytotoxicity against monocyte-derived dendritic cells through natural killer cells. (2025) Sauerer T, Bremm F, Beenen A, Heger L, Dudziak D, Bosch NC, Erdmann M, et al. Journal article Guidelines for preparation and flow cytometry analysis of human nonlymphoid tissue DC (2025) Dudziak D, Heger L, Agace WW, Bakker J, de Gruijl TD, Dress RJ, Dutertre CA, et al. Journal article Zinc deficiency-associated dermatitis in a prematurely born infant (2025) Grötsch J, Sticherling M Journal article A yet undescribed IRF6 variant causes a new type of ectodermal dysplasia with natal teeth (2025) Peschel N, Willershausen I, Schliep S, Sticherling M, Schneider H Journal article Association Between Local Skin Reactions and Efficacy with 5-Fluorouracil 4% Cream in Actinic Keratosis: A Post-Hoc Analysis of Two Randomised Clinical Trials (2025) Heppt M, Trin K, Mille AC, Groc M, Delarue A, Bégeault N Journal article Multimodal Profiling of Peripheral Blood Identifies Proliferating Circulating Effector CD4+ T Cells as Predictors for Response to Integrin α4β7-Blocking Therapy in Inflammatory Bowel Disease. (2025) Horn V, Cancino CA, Steinheuer LM, Obermayer B, Fritz K, Nguyen AL, Juhran KS, et al. Journal article